You Searched For: 2-Keto-D-gluconic+acid+hemicalcium+salt+monohydrate

Supplier: Alfa Aesar

Description: L-Cystine disodium salt monohydrate 98

Catalog Number: (J66500.03)

Supplier: Alfa Aesar

Description: Cloxacillin sodium salt monohydrate ≥95%

UOM: 1 * 1 g

Catalog Number: (MOLE24815696-5G)

Supplier: Molekula

Description: 1-Naphthyl phosphate disodium salt monohydrate

UOM: 1 * 5 g

 This is a MarketSource item. Additional charges may apply

Catalog Number: (BOSSBS-13453R-FITC)

Supplier: Bioss

Description: GMD is a 372 amino acid protein that utilizes NADP as a cofactor to catalyze the conversion of GDP-mannose to GDP-4-keto-6-deoxymannose. GMD mutations are involved in resistance to TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis. The gene encoding GMD maps to human chromosome 6, which contains 170 million base pairs and comprises nearly 6% of the human genome. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer, suggesting the presence of a cancer susceptibility locus. Additionally, Porphyria cutanea tarda, Parkinson's disease, Stickler syndrome and a susceptibility to bipolar disorder are all associated with genes that map to chromosome 6.

UOM: 1 * 100 µl

Catalog Number: (95120-10G)

Supplier: Merck

Description: Violuric acid monohydrate ≥97.0% (by titrimetric analysis) for spectrophotometric determination of Co, Supelco®

UOM: 1 * 10 g

Supplier: MP Biomedicals

Description: α - Naphthyl phosphate disodium salt is a substrate for determination of phosphatase.

Supplier: Merck

Description: p-Toluenesulphonic acid monohydrate for synthesis, Sigma-Aldrich®

Catalog Number: (BOSSBS-11784R-CY7)

Supplier: Bioss

Description: SPR, also known as sepiapterin reductase, is a homodimeric cytoplasmic protein that belongs to the sepiapterin reductase family. SPR functions as an NADH-dependent aldo-keto reductase and specifically catalyzes the reduction of pteridine derivatives. In addition, SPR plays an important role in tetrahydrobiopterin (BH4) biosynthesis, catalyzing the final reduction step of the synthesis pathway. BH4 is an essential cofactor for the hydroxylation of the aromatic amino acids (tryptophan, tyrosine and phenylalanine) and is required for proper dopamine synthesis. Mutations in the gene encoding SPR can cause sepiapterin reductase deficiency, a monoamine neurotransmitter deficiency without hyperphenylalaninemia. Sepiapterin reductase deficiency interferes with BH4 synthesis, resulting in DOPA-responsive dystonia and a variety of other human diseases. In addition, SPR mRNA expression is increased in the brain of Parkinson’s Disease (PD) patients, suggesting that SPR may play a role in PD.

UOM: 1 * 100 µl

Supplier: MP Biomedicals

Description: Chlorhexidine digluconate, a bis(biguanide) family cationic broad spectrum antibiotic is an antiseptic and disinfectant agent. It is effective against a wide range of bacteria, some fungi and some viruses, and an agent for the prevention of gingivitis. Chlorhexidine digluconate solution inhibits oxygen utilization which leads to a reduction in bacterial ATP . Commercial ophthalmic products have used this agent to replace thimerosal as a preservative; however, it can cause skin irritation.

MSDS

Catalog Number: (BOSSBS-13453R-CY3)

Supplier: Bioss

Description: GMD is a 372 amino acid protein that utilizes NADP as a cofactor to catalyze the conversion of GDP-mannose to GDP-4-keto-6-deoxymannose. GMD mutations are involved in resistance to TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis. The gene encoding GMD maps to human chromosome 6, which contains 170 million base pairs and comprises nearly 6% of the human genome. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer, suggesting the presence of a cancer susceptibility locus. Additionally, Porphyria cutanea tarda, Parkinson's disease, Stickler syndrome and a susceptibility to bipolar disorder are all associated with genes that map to chromosome 6.

UOM: 1 * 100 µl

Catalog Number: (BOSSBS-13453R-CY5)

Supplier: Bioss

Description: GMD is a 372 amino acid protein that utilizes NADP as a cofactor to catalyze the conversion of GDP-mannose to GDP-4-keto-6-deoxymannose. GMD mutations are involved in resistance to TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis. The gene encoding GMD maps to human chromosome 6, which contains 170 million base pairs and comprises nearly 6% of the human genome. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer, suggesting the presence of a cancer susceptibility locus. Additionally, Porphyria cutanea tarda, Parkinson's disease, Stickler syndrome and a susceptibility to bipolar disorder are all associated with genes that map to chromosome 6.

UOM: 1 * 100 µl

Supplier: Merck

Description: p-Toluenesulphonic acid monohydrate, EMSURE® ACS for analysis, Supelco®

Supplier: Merck

Description: 8-Hydroxyquinoline-5-sulphonic acid monohydrate for synthesis, Sigma-Aldrich®

Catalog Number: (BOSSBS-13453R-A350)

Supplier: Bioss

Description: GMD is a 372 amino acid protein that utilizes NADP as a cofactor to catalyze the conversion of GDP-mannose to GDP-4-keto-6-deoxymannose. GMD mutations are involved in resistance to TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis. The gene encoding GMD maps to human chromosome 6, which contains 170 million base pairs and comprises nearly 6% of the human genome. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer, suggesting the presence of a cancer susceptibility locus. Additionally, Porphyria cutanea tarda, Parkinson's disease, Stickler syndrome and a susceptibility to bipolar disorder are all associated with genes that map to chromosome 6.

UOM: 1 * 100 µl

Catalog Number: (BOSSBS-13453R-CY7)

Supplier: Bioss

Description: GMD is a 372 amino acid protein that utilizes NADP as a cofactor to catalyze the conversion of GDP-mannose to GDP-4-keto-6-deoxymannose. GMD mutations are involved in resistance to TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-induced apoptosis. The gene encoding GMD maps to human chromosome 6, which contains 170 million base pairs and comprises nearly 6% of the human genome. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer, suggesting the presence of a cancer susceptibility locus. Additionally, Porphyria cutanea tarda, Parkinson's disease, Stickler syndrome and a susceptibility to bipolar disorder are all associated with genes that map to chromosome 6.

UOM: 1 * 100 µl

Catalog Number: (MOLE25302670-25MG)

Supplier: Molekula

Description: D-(-)-Luciferin sodium salt monohydrate

UOM: 1 * 25 mg

 This is a MarketSource item. Additional charges may apply